-The Economic Times NEW DELHI: Civil society group All India Drug Action Network (AIDAN) has sent legal notices to Niti Aayog CEO and secretaries to the health ministry, department of pharmaceuticals and department of industrial policy and promotion over their talks to cut powers of the National Pharmaceutical Pricing Authority. The group has termed the move “anti-national” and “anti-people”, adding that it affects an ongoing case at the Supreme Court over various...
More »SEARCH RESULT
Total Matching Records found : 16
Out of essentials list, prices of 100 drugs may increase by 10% -Sushmi Dey
-The Times of India NEW DELHI: Prices of around 100 medicines, including those for Alzheimer's, diabetes and hypertension, could rise by up to 10% after they were removed from the national list of essential medicines. Though the move is likely to impact consumers, it comes as a relief to drug makers reeling under stringent price regulation for over a year. Overruling a previous order by the drug price regulator, the Centre has...
More »Pharma companies may be fined for freebies to doctors -Sushmi Dey
-The Times of India NEW DELHI: Pharma companies may have to cough up huge penalties for unethical and illegal practices like offering freebies, gifts and foreign trips to doctors for pushing the sales of their products. The government is set to make mandatory the uniform code of conduct for pharmaceutical marketing practices, which have so far been voluntary. The department of pharmaceuticals (DoP) is working on a draft which will curb unethical...
More »Medical devices like stents, implants set to come under price control -Rupali Mukherjee
-The Times of India MUMBAI: Faced with complaints of overpricing of medical devices like cardiac stents and implants, the government seems to be finally getting its act together. According to a government official, in a string of measures to regulate the industry under the Draft National Medical Device Policy, it has recommended creating an autonomous body — the National Medical Devices Authority (NDMA) — pricing control for medical devices by including them...
More »Govt resurrects Jan Aushadhi, to push generic drugs cheap
-Hindustan Times The government is set to re-launch its pharmacy chain, Jan Aushadhi, to sell generic drugs ranging from anti-biotics, anti-cardiac, anti-infective and gastro intestinal drugs at prices at least half of branded drugs. The project would be launched in six states on a pilot basis from June 21, where 5,000 stores would be opened across the country in a phased manner. The scheme failed in 2008 due to poor supply-chain management. “Now, we...
More »
